 Xeris Biopharma Holdings NASDAQ:XERS Inc has noted that Tetris Pharma - its commercialization partner for Ogluo in the UK, EEA, and Switzerland - is to be acquired by Arecor Therapeutics PLC AIM:AREC, a UK-based, publicly traded, globally focused biopharmaceutical company. Contingent upon a successful capital offering by Arecor, under the terms of the proposed acquisition, the UK-based company has agreed to acquire Tetris Pharma and will continue to commercialize Ogluo in the UK and EEA. 